 |
 |
| Cell therapy enabling safe haploidentical haematopoietic stem cell transplantation (HSCT) for the treatment of haematological malignancies. Phase III in high-risk acute leukaemia started in Italy |
 |
|
 |
 |
A novel VTA for the treatment of solid tumours. Phase III trial in mesothelioma started in April 2010. Phase II trials ongoing in five indications: colorectal cancer, liver cancer, small-cell lung cancer, non-small-cell lung cancer, and ovarian cancer
|
 |
|
|
